Double Cost Of Revenue vs Net Income From Continuing Ops Analysis

002901 Stock

33.19 0.42 1.28%

Double Medical financial indicator trend analysis is much more than just examining Double Medical Technology latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Double Medical Technology is a good investment. Please check the relationship between Double Medical Cost Of Revenue and its Net Income From Continuing Ops accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Double Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Cost Of Revenue vs Net Income From Continuing Ops

Cost Of Revenue vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Double Medical Technology Cost Of Revenue account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have no relationship.

The correlation between Double Medical's Cost Of Revenue and Net Income From Continuing Ops is 0.01. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Double Medical Technology, assuming nothing else is changed. The correlation between historical values of Double Medical's Cost Of Revenue and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Double Medical Technology are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Cost Of Revenue i.e., Double Medical's Cost Of Revenue and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

0.01

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Double Medical Technology income statement and represents the costs associated with goods and services Double Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Net Income From Continuing Ops

Most indicators from Double Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Double Medical Technology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Double Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of December 2, 2024, Tax Provision is expected to decline to about 12.7 M. In addition to that, Selling General Administrative is expected to decline to about 440.3 M

	2021	2022	2023	2024 (projected)
Net Interest Income	13.7M	17.6M	22.4M	16.3M
Tax Provision	111.0M	37.9M	13.4M	12.7M

Net Interest Income Tax Provision

Double Medical fundamental ratios Correlations

	Other Liab	Net Tangible Assets	Retained Earnings	Other Assets	Other Stockholder Equity	Deferred Long Term Liab	Common Stock	Property Plant Equipment	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Total Current Assets	Intangible Assets	Common Stock Shares Outstanding	Short Term Investments
Other Liab		0.87	0.88	0.8	-0.78	0.64	0.74	0.91	0.88	0.36	0.77	0.87	0.91	0.71	0.86	-0.65	0.86	0.66	0.56	0.86	-0.06	0.74	0.87	0.8	0.39	0.84
Net Tangible Assets	0.87		0.97	0.76	-0.78	0.74	0.89	0.95	0.97	0.32	0.79	0.98	0.92	0.89	0.9	-0.9	0.87	0.79	0.56	0.91	0.27	0.75	0.98	0.84	0.42	0.84
Retained Earnings	0.88	0.97		0.75	-0.84	0.74	0.82	0.93	0.93	0.48	0.79	0.95	0.93	0.78	0.86	-0.87	0.95	0.77	0.52	0.86	0.24	0.74	0.95	0.88	0.44	0.93
Other Assets	0.8	0.76	0.75		-0.45	0.75	0.75	0.77	0.8	0.18	0.83	0.79	0.86	0.73	0.78	-0.61	0.76	0.68	0.67	0.77	0.05	0.8	0.79	0.57	0.62	0.64
Other Stockholder Equity	-0.78	-0.78	-0.84	-0.45		-0.68	-0.64	-0.8	-0.8	-0.31	-0.73	-0.82	-0.78	-0.56	-0.77	0.69	-0.82	-0.67	-0.54	-0.77	-0.03	-0.7	-0.8	-0.93	-0.5	-0.89
Deferred Long Term Liab	0.64	0.74	0.74	0.75	-0.68		0.77	0.81	0.86	-0.01	0.94	0.84	0.83	0.67	0.89	-0.63	0.74	0.92	0.83	0.86	0.05	0.93	0.84	0.83	0.79	0.75
Common Stock	0.74	0.89	0.82	0.75	-0.64	0.77		0.81	0.9	0.04	0.88	0.89	0.76	0.93	0.85	-0.87	0.65	0.69	0.81	0.86	0.3	0.87	0.92	0.68	0.6	0.67
Property Plant Equipment	0.91	0.95	0.93	0.77	-0.8	0.81	0.81		0.97	0.3	0.82	0.96	0.96	0.78	0.97	-0.73	0.89	0.89	0.59	0.96	0.09	0.78	0.96	0.92	0.41	0.88
Total Assets	0.88	0.97	0.93	0.8	-0.8	0.86	0.9	0.97		0.17	0.89	0.99	0.95	0.88	0.98	-0.82	0.85	0.87	0.71	0.98	0.16	0.86	1.0	0.89	0.55	0.84
Other Current Liab	0.36	0.32	0.48	0.18	-0.31	-0.01	0.04	0.3	0.17		0.01	0.2	0.29	-0.04	0.08	-0.26	0.58	0.11	-0.3	0.04	0.19	-0.06	0.2	0.28	-0.28	0.57
Total Current Liabilities	0.77	0.79	0.79	0.83	-0.73	0.94	0.88	0.82	0.89	0.01		0.87	0.83	0.76	0.89	-0.69	0.74	0.79	0.92	0.88	0.07	1.0	0.88	0.79	0.83	0.76
Total Stockholder Equity	0.87	0.98	0.95	0.79	-0.82	0.84	0.89	0.96	0.99	0.2	0.87		0.95	0.89	0.95	-0.87	0.87	0.85	0.66	0.96	0.2	0.83	1.0	0.89	0.56	0.84
Accounts Payable	0.91	0.92	0.93	0.86	-0.78	0.83	0.76	0.96	0.95	0.29	0.83	0.95		0.77	0.94	-0.73	0.93	0.86	0.58	0.93	0.03	0.79	0.94	0.89	0.52	0.87
Cash	0.71	0.89	0.78	0.73	-0.56	0.67	0.93	0.78	0.88	-0.04	0.76	0.89	0.77		0.81	-0.87	0.6	0.63	0.66	0.85	0.41	0.74	0.9	0.6	0.52	0.54
Non Current Assets Total	0.86	0.9	0.86	0.78	-0.77	0.89	0.85	0.97	0.98	0.08	0.89	0.95	0.94	0.81		-0.69	0.81	0.92	0.73	1.0	0.04	0.87	0.96	0.9	0.55	0.81
Non Currrent Assets Other	-0.65	-0.9	-0.87	-0.61	0.69	-0.63	-0.87	-0.73	-0.82	-0.26	-0.69	-0.87	-0.73	-0.87	-0.69		-0.72	-0.59	-0.51	-0.71	-0.44	-0.66	-0.87	-0.67	-0.49	-0.69
Net Receivables	0.86	0.87	0.95	0.76	-0.82	0.74	0.65	0.89	0.85	0.58	0.74	0.87	0.93	0.6	0.81	-0.72		0.78	0.43	0.78	0.08	0.69	0.86	0.88	0.43	0.96
Good Will	0.66	0.79	0.77	0.68	-0.67	0.92	0.69	0.89	0.87	0.11	0.79	0.85	0.86	0.63	0.92	-0.59	0.78		0.61	0.88	0.01	0.77	0.84	0.88	0.5	0.78
Non Current Liabilities Total	0.56	0.56	0.52	0.67	-0.54	0.83	0.81	0.59	0.71	-0.3	0.92	0.66	0.58	0.66	0.73	-0.51	0.43	0.61		0.74	0.02	0.95	0.69	0.57	0.86	0.5
Inventory	0.86	0.91	0.86	0.77	-0.77	0.86	0.86	0.96	0.98	0.04	0.88	0.96	0.93	0.85	1.0	-0.71	0.78	0.88	0.74		0.06	0.87	0.96	0.88	0.55	0.78
Other Current Assets	-0.06	0.27	0.24	0.05	-0.03	0.05	0.3	0.09	0.16	0.19	0.07	0.2	0.03	0.41	0.04	-0.44	0.08	0.01	0.02	0.06		0.06	0.21	-0.02	0.05	0.04
Total Liab	0.74	0.75	0.74	0.8	-0.7	0.93	0.87	0.78	0.86	-0.06	1.0	0.83	0.79	0.74	0.87	-0.66	0.69	0.77	0.95	0.87	0.06		0.85	0.75	0.85	0.72
Total Current Assets	0.87	0.98	0.95	0.79	-0.8	0.84	0.92	0.96	1.0	0.2	0.88	1.0	0.94	0.9	0.96	-0.87	0.86	0.84	0.69	0.96	0.21	0.85		0.88	0.55	0.84
Intangible Assets	0.8	0.84	0.88	0.57	-0.93	0.83	0.68	0.92	0.89	0.28	0.79	0.89	0.89	0.6	0.9	-0.67	0.88	0.88	0.57	0.88	-0.02	0.75	0.88		0.48	0.93
Common Stock Shares Outstanding	0.39	0.42	0.44	0.62	-0.5	0.79	0.6	0.41	0.55	-0.28	0.83	0.56	0.52	0.52	0.55	-0.49	0.43	0.5	0.86	0.55	0.05	0.85	0.55	0.48		0.43
Short Term Investments	0.84	0.84	0.93	0.64	-0.89	0.75	0.67	0.88	0.84	0.57	0.76	0.84	0.87	0.54	0.81	-0.69	0.96	0.78	0.5	0.78	0.04	0.72	0.84	0.93	0.43

Click cells to compare fundamentals

Double Medical Account Relationship Matchups

Double Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Liab	30.7M	59.6M	61.8M	56.1M	64.5M	48.1M
Net Tangible Assets	1.4B	1.7B	2.0B	2.3B	2.6B	1.5B
Retained Earnings	891.0M	1.3B	1.6B	1.2B	1.3B	920.1M
Other Assets	6.6M	100.9M	9.4M	66.4M	76.4M	80.2M
Other Stockholder Equity	(134.0K)	112.6K	(2.5M)	(1.7M)	(1.5M)	(1.4M)
Deferred Long Term Liab	3.1M	2.8M	2.4M	57.3M	65.9M	69.2M
Common Stock	401.9M	402.3M	402.2M	405.1M	465.9M	429.3M
Property Plant Equipment	276.9M	443.0M	513.7M	698.7M	803.5M	402.2M
Total Assets	2.2B	2.6B	3.4B	3.9B	4.6B	2.8B
Other Current Liab	153.0M	180.8M	289.1M	16.7M	21.3M	20.3M
Total Current Liabilities	425.8M	441.8M	721.8M	716.6M	1.2B	1.2B
Total Stockholder Equity	1.7B	2.1B	2.5B	3.0B	3.1B	2.2B
Accounts Payable	211.1M	179.8M	296.3M	345.4M	281.6M	193.5M
Cash	764.6M	562.9M	410.2M	992.7M	1.2B	737.2M
Non Current Assets Total	591.1M	663.4M	984.8M	1.2B	1.5B	799.6M
Non Currrent Assets Other	93.7M	676.2K	899.5K	4.7M	1.9M	1.8M
Net Receivables	242.7M	290.9M	467.8M	324.7M	242.4M	245.0M
Non Current Liabilities Total	59.6M	61.8M	69.7M	114.5M	325.4M	341.7M
Inventory	457.1M	542.0M	670.2M	987.4M	1.2B	615.0M
Other Current Assets	24.6M	21.7M	36.0M	13.0M	26.1M	28.8M
Total Liab	485.3M	503.7M	791.5M	831.1M	1.5B	1.6B
Total Current Assets	1.6B	2.0B	2.4B	2.7B	3.2B	2.0B
Intangible Assets	28.7M	121.7M	148.6M	143.2M	136.9M	93.4M
Common Stock Shares Outstanding	402.3M	402.2M	405.1M	417.1M	414.0M	446.7M
Short Term Investments	158.7M	504.0M	769.7M	358.7M	433.2M	350.3M
Net Invested Capital	1.7B	2.1B	2.5B	3.0B	3.6B	2.5B
Net Working Capital	1.2B	1.5B	1.7B	2.0B	2.0B	1.7B
Capital Stock	402.3M	402.2M	405.1M	414.0M	476.1M	447.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Other Information on Investing in Double Stock

Balance Sheet is a snapshot of the financial position of Double Medical Technology at a specified time, usually calculated after every quarter, six months, or one year. Double Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Double Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Double currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Double Cost Of Revenue vs Net Income From Continuing Ops Analysis

Cost Of Revenue vs Net Income From Continuing Ops

Cost Of Revenue vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Net Income From Continuing Ops

Double Medical fundamental ratios Correlations

Double Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Double Medical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Double Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Total Stockholder Equity
Inventory	+ 1.0	Non Current Assets Total
Total Stockholder Equity	+ 0.99	Total Assets
Total Stockholder Equity	+ 0.98	Net Tangible Assets

Intangible Assets	- 0.93	Other Stockholder Equity
Non Currrent Assets Other	- 0.9	Net Tangible Assets
Short Term Investments	- 0.89	Other Stockholder Equity
Total Current Assets	- 0.87	Non Currrent Assets Other
Non Currrent Assets Other	- 0.87	Cash
Non Currrent Assets Other	- 0.87	Total Stockholder Equity